Due to popularity of the medications, GLP-1s were in short supply up until recently. Obesity is a common issue among ...

Eli Lilly announced that its breakthrough drug, Mounjaro (tirzepatide), has received marketing authorization from India’s ...

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs.

Indianapolis-based Eli Lilly announced its definitive agreement to acquire Verge, a gene-editing startup, for up to $1.3 billion at $10.50 a share -- a premium of 67.5% at last closing -- with the ...

The Japanese biotech behind Eli Lilly’s new blockbuster obesity pill believes it could be used with an anti-muscle wasting drug it has developed to create a new standard of patient care for ...

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.

Business. Eli Lilly stock spikes as efficacy of new weight-loss pill rivals Ozempic The breakthrough puts the market one step closer to having a needle-free option to address obesity and diabetes.

Eli Lilly said clinical results of its ... A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the ... a health care economist ...

Eli Lilly and Company is the world's most valuable Pharma thanks to tirzepatide, a groundbreaking GLP-1 weight-loss and Type 2 Diabetes drug, marketed and sold as Zepbound / Mounjaro. Hims & Hers ...

Eli Lilly also works with telehealth companies 9amHealth and Form Health, through its LillyDirect channel, to offer consumers direct access to weight loss and diabetes medications.

Eli Lilly & Co. is adding Alzheimer’s disease resources to the online platform it launched a year ago to sell obesity, diabetes and migraine medicines. Patients will now be able to use ...